<DOC>
	<DOCNO>NCT01296711</DOCNO>
	<brief_summary>The purpose study evaluate long term safety tolerability CDP6038 treatment adult subject active rheumatoid arthritis ( RA ) complete RA0056 .</brief_summary>
	<brief_title>Open-label Study Assess Safety Efficacy CDP6038 Patients Who Completed RA0056</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Subject complete RA0056 study ( Week 12 Visit ) Subject must maintain stable dose ( route ) methotrexate ( MTX ) 12.5 25mg/week RA0056 , plan maintain dose route administration least 12 week Female subject must either postmenopausal least 1 year , surgically incapable childbearing , effectively practice acceptable method contraception ( either oral/parenteral/implantable hormonal contraceptive , intrauterine device , barrier spermicide ) . Abstinence consider acceptable method contraception study Female subject childbearing potential must agree use 2 method adequate contraception study 6 month ( 24 week ) last CDP6038 dose Male subject must agree ensure female partner ( ) use adequate contraception study 12 week subject receives last dose CDP6038 Subject ongoing serious adverse event RA0056 study Female subject childbearing potential positive pregnancy test plan become pregnant study within 6 month ( 24 week ) follow last dose study medication Subject evidence active latent tuberculosis Subject receive biologic response modifier synthetic diseasemodifying antirheumatic drug MTX Subject alcohol consumption 1 unit per weekday . One unit equal 1 glass beer lager ( ~330mL ) , glass wine ( 125mL ) , measure spirits/hard liquor ( 25mL ) Subject condition RA0056 ( eg , clinically significant laboratory value , frequent adverse event ) Investigator 's Sponsor 's judgment would make subject unsuitable inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>CDP6038</keyword>
	<keyword>Interleukin-6</keyword>
</DOC>